Go Industries

GO Therapeutics is a biotechnology company focused on developing a new class of cancer therapies that target cancer-specific glycoproteins. By leveraging its proprietary glycoproteomics platform, the company identifies unique O-linked glycan epitopes that are present on cancer cells but absent on healthy tissue, allowing for the creation of highly specific antibodies. These antibodies serve as the foundation for various modalities, including antibody-drug conjugates (ADCs), bispecific T-cell engagers, and CAR-T therapies, aimed at treating previously intractable solid tumors. The company has established significant strategic partnerships with major pharmaceutical players like Astellas Pharma and Roche to advance its pipeline of precision immuno-oncology treatments.